Last $14.49 USD
Change Today +0.45 / 3.21%
Volume 312.9K
INFI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 1:05 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Adelene Q. Perkins

Chairman of The Board, Chief Executive Officer and President, Infinity Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 1 different industries.

See Board Relationships
54$3,861,161
As of Fiscal Year 2013

Background*

Ms. Adelene Q. Perkins has been the Chief Executive Officer of Infinity Pharmaceuticals, Inc., since January 2, 2010 and its Chairman since November 2012. Ms. Perkins has been the President of Infinity Pharmaceuticals Inc. since October 2008. Ms. Perkins served as Principal Financial Officer of Infinity Pharmaceuticals,Inc. and is responsible for all of Infinity's business functions, including corporate and product strategy, business development, finance, organizational ...

Read Full Background

Corporate Headquarters*

780 Memorial Drive
Cambridge, Massachusetts 02139

United States

Phone: 617-453-1000
Fax: 617-453-1001

Board Members Memberships*

2010-Present
Chairman of The Board, Chief Executive Officer and President

Education*

MBA
Harvard Business School
BS
Villanova University

Other Affiliations*

Annual Compensation*

Salary$552,000
Total Annual Compensation$552,000

Stock Options*

All Other Compensation$8,616
Exercisable Options1,083,184
Exercisable Options Value$5,819,138
Unexercisable Options251,388
Unexercisable Options Value$879,623
Total Value of Options$6,698,761
Total Number of Options1,334,572

Total Compensation*

Total Annual Cash Compensation$560,616
Total Short Term Compensation$552,000
Other Long Term Compensation$8,616
Total Calculated Compensation$3,861,161
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INFI:US $14.49 USD +0.45

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INFINITY PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.